3
Clinical Trials associated with Recombinant Zoster Vaccine(CHO Cell)(Patronus Biotech) / Not yet recruitingPhase 1 评价重组带状疱疹疫苗(CHO细胞)在40周岁及以上人群中接种的安全性和免疫原性的随机、盲法、平行对照的Ⅰ期临床试验
[Translation] A randomized, blinded, parallel-controlled phase I clinical trial to evaluate the safety and immunogenicity of a recombinant herpes zoster vaccine (CHO cells) in people aged 40 years and above
评价40周岁及以上人群接种重组带状疱疹疫苗(CHO细胞)的安全性、免疫原性和免疫持久性
[Translation] To evaluate the safety, immunogenicity and immune persistence of recombinant herpes zoster vaccine (CHO cells) in people aged 40 years and above
A Phase I, Randomized, Observer-blinded, Parallel-Controlled, Dose Escalation Clinical Trial to Assess the Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older
This phase 1 study in China will evaluate the safety and immunogenicity of the Recombinant Zoster Vaccine, LYB004 in adults aged 40 years and older.
/ Active, not recruitingPhase 1 A Phase I, Randomized, Observer-blinded, Positive-Controlled, Dose Escalation Clinical Trial to Assess the Safety and Immunogenicity of the Recombinant Zoster Vaccine (CHO Cell), LYB004 in Adults Aged 50 to 70 Years
This phase 1 study in Australia will evaluate the safety and immunogenicity of the Recombinant Zoster Vaccine (CHO Cell), LYB004 in Adults Aged 50 to 70 Years.
100 Clinical Results associated with Recombinant Zoster Vaccine(CHO Cell)(Patronus Biotech)
100 Translational Medicine associated with Recombinant Zoster Vaccine(CHO Cell)(Patronus Biotech)
100 Patents (Medical) associated with Recombinant Zoster Vaccine(CHO Cell)(Patronus Biotech)
100 Deals associated with Recombinant Zoster Vaccine(CHO Cell)(Patronus Biotech)